SCHEMBL7314294

SCHEMBL7314294

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(OCCN3CCCC3)cc2)C(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.66
ITGB1 P05556 6/20 0.57
ITGA5 P08648 3/20 0.57
ITGB7 P26010 1/20 0.52
ALDH1A1 P00352 1/20 0.51
ITGAV P06756 1/20 0.50
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
KMT2A Q03164 1/20 0.48
ITGA2 P17301 1/20 0.47
KCNQ1 P51787 1/20 0.47
FKBP1A P62942 2/20 0.47
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
MMP1 P03956 1/20 0.47
ADAM17 P78536 1/20 0.47
KCNH2 Q12809 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7315890 0.99 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7317528 0.99 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7510457 0.97 ITGA4 (0.63) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7511221 0.95 ITGA4 (0.63) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7318157 0.95 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7321689 0.94 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7317569 0.92 ITGA4 (0.58) ITGA4ITGB1ITGA5KMT2AKCNQ1
SCHEMBL7322188 0.91 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7316261 0.91 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7315373 0.90 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGB7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed